On the Record · Solventum
Solventum acquisitions, on the record
The businesses Solventum bought and sold, as its annual reports describe them, with the cash it reported paying for acquisitions each year and every deal filing since 2016.
Deals its annual reports describe
| Business | Deal | When | Value |
|---|---|---|---|
dental local anesthetic business sold to Pierrel S.p.AWord for word“In August 2023, 3M completed the sale of assets associated with its dental local anesthetic business (part of the Dental Solutions segment) to Pierrel S.p.A for approximately $ 60 million in cash.” 10-K for 2024 | divestiture | August 2023 | approximately $ 60 million |
Purification and Filtration businessWord for word“For example, on September 2, 2025, Solventum announced the close of its sale of the Purification & Filtration business ("P&F") to Thermo Fisher Scientific Inc. for $4.0 billion in cash before customary adjustments.” 10-K for 2025 | divestiture | September 2, 2025 | $4.0 billion in cash before customary adjustments |
Acera SurgicalWord for word“In addition, on December 23, 2025, Solventum acquired Acera Surgical ("Acera"), a privately held bioscience company focused on developing and commercializing fully engineered materials for regenerative wound care, for cash consideration of $696 million, net of cash acquired, plus a future payment of $125 million dependent on the acquired business achieving a sales-based milestone.” 10-K for 2025 | acquisition | December 23, 2025 | $696 million |
| Fiscal year ended | Cash paid for acquisitions (net of cash acquired) | Cash received from selling businesses | Goodwill from acquisitions |
|---|---|---|---|
| 2022-12-31 | — | $0 | — |
| 2023-12-31 | $0 | $60 million | $0 |
| 2024-12-31 | $0 | $0 | $0 |
| 2025-12-31 | $696 million | $3.89 billion | $441 million |
Deal filings since 2016
- 2025-09-02 Form 8-K, Item 2.01: Completion of Acquisition or Disposition of Assets
- 2025-06-25 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2025-02-27 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2024-04-04 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
Read from Solventum’s annual reports (10-K for 2025, 10-K for 2024) and the financial data it files with the SEC, as of 2026-02-27. Every quotation is word for word from the filing linked beside it; how these pages are built and checked. The full record is in its company data sheet.